FibroBiologics, Inc. Shares Authorized
FibroBiologics, Inc. (FBLG) had Shares Authorized of 300.00 million shares as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2026-07-31
- 2026-06-30: Common Stock, Shares Authorized 300.00M shares.
- 2026-03-31: Common Stock, Shares Authorized 300.00M shares.
- 2025-12-31: Common Stock, Shares Authorized 300.00M shares.
- 2025-09-30: Common Stock, Shares Authorized 300.00M shares.
| Period end | Common Stock, Shares Authorized |
|---|---|
| 2026-06-30 | 300.00M shares 10-Q · filed 2026-07-31 |
| 2026-03-31 | 300.00M shares 10-Q · filed 2026-04-30 |
| 2025-12-31 | 300.00M shares 10-K · filed 2026-02-24 |
| 2025-09-30 | 300.00M shares 10-Q · filed 2025-10-31 |
| 2025-06-30 | 300.00M shares 10-Q · filed 2025-07-31 |
| 2025-03-31 | 100.00M shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 100.00M shares 10-K · filed 2026-02-24 |
| 2024-03-31 | 100.00M shares 10-K · filed 2026-02-24 |
| 2023-04-30 | 10.00M shares 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 |